IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 78 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $38,000 | -79.8% | 20,794 | -76.7% | 0.00% | -80.0% |
| Q4 2017 | $188,000 | +116.1% | 89,256 | +129.1% | 0.01% | +150.0% |
| Q3 2017 | $87,000 | +81.2% | 38,963 | +38.3% | 0.00% | +100.0% |
| Q2 2017 | $48,000 | -52.9% | 28,178 | -31.9% | 0.00% | -66.7% |
| Q1 2017 | $102,000 | +142.9% | 41,360 | +48.8% | 0.00% | +200.0% |
| Q4 2016 | $42,000 | -14.3% | 27,788 | +44.8% | 0.00% | 0.0% |
| Q3 2016 | $49,000 | +75.0% | 19,188 | +6.7% | 0.00% | 0.0% |
| Q2 2016 | $28,000 | -22.2% | 17,988 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $36,000 | -36.8% | 17,988 | -1.6% | 0.00% | -50.0% |
| Q4 2015 | $57,000 | -10.9% | 18,288 | -3.7% | 0.00% | 0.0% |
| Q3 2015 | $64,000 | -22.0% | 18,993 | -14.1% | 0.00% | -33.3% |
| Q1 2015 | $82,000 | +134.3% | 22,100 | +83.3% | 0.00% | +200.0% |
| Q2 2014 | $35,000 | -63.9% | 12,055 | -49.4% | 0.00% | -75.0% |
| Q1 2014 | $97,000 | – | 23,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|